You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sunitinib

Showing 51 - 75 of 196
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Advanced Solid Tumors Trial in Amsterdam (Sunitinib, Sorafenib, Erlotinib)

Completed
  • Cancer
  • Advanced Solid Tumors
  • Sunitinib
  • +9 more
  • Amsterdam, Netherlands
    VUMedical Center
Apr 14, 2021

Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Tumors Trial run by the NCI (Sunitinib, Everolimus)

Terminated
Has Results
  • Neuroendocrine Tumors
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2020

Advanced Renal Cell Carcinoma Trial (Sunitinib, Trebananib)

Completed
Has Results
  • Advanced Renal Cell Carcinoma
  • (no location specified)
Jun 10, 2020

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Kidney Cancer Trial in United States (Gemcitabine, Sunitinib)

Completed
Has Results
  • Kidney Cancer
  • Birmingham, Alabama
  • +98 more
Dec 29, 2021

Metastatic Renal Cell Carcinoma Trial in Worldwide (Tivozanib, Sunitinib)

Terminated
Has Results
  • Metastatic Renal Cell Carcinoma
  • Los Angeles, California
  • +37 more
Oct 5, 2020

Gastrointestinal Stromal Tumor(GIST) Trial in China (Ripretinib, Sunitinib)

Recruiting
  • Gastrointestinal Stromal Tumor(GIST)
  • Beijing, Beijing, China
  • +17 more
Dec 17, 2020

Pancreatic Neuroendocrine Tumour Metastatic Trial in Spain (Sunitinib)

Completed
  • Pancreatic Neuroendocrine Tumour Metastatic
  • Sunitinib
  • Oviedo, Asturias, Spain
  • +8 more
Mar 3, 2020

Genitourinary Cancer, Kidney Cancer Trial in United States (Sunitinib, Questionnaire)

Completed
Has Results
  • Genitourinary Cancer
  • Kidney Cancer
  • Sunitinib
  • Questionnaire
  • Stanford, California
  • +4 more
Feb 14, 2020

Cancer, High-grade Glioma Trial in Amsterdam (Sunitinib, vandetanib, Erlotinib)

Unknown status
  • Cancer
  • High-grade Glioma
  • Sunitinib
  • +2 more
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Oct 6, 2020

Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Trial in Worldwide (bempegaldesleukin, sunitinib, nivolumab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Metastatic Renal Cell Carcinoma
  • bempegaldesleukin
  • +3 more
  • Anchorage, Alaska
  • +108 more
Mar 31, 2022

Advanced Renal Cancer Trial in China (TQB2450, Anlotinib, Sunitinib)

Recruiting
  • Advanced Renal Cancer
  • Hefei, Anhui, China
  • +25 more
Sep 9, 2020

Solid Tumors, NSCLC, Renal Cell Carcinoma Trial in China (Lenvatinib + Envafolimab, Sunitinib)

Recruiting
  • Solid Tumors
  • +3 more
  • Lenvatinib + Envafolimab
  • Sunitinib
  • Benbu, Anhui, China
  • +22 more
Jun 28, 2022

Renal Cell Carcinoma Trial in Worldwide (Lenvatinib, Everolimus, Pembrolizumab)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma
  • Stanford, California
  • +182 more
Jul 1, 2022

Sarcoma, Soft Tissue Trial in New York (Sunitinib)

Terminated
Has Results
  • Sarcoma, Soft Tissue
  • Sunitinib
  • New York, New York
    Columbia University Medical Center
Oct 15, 2019

Metastatic Uveal Melanoma Trial in Wirral (Dacarbazine, Sunitinib)

Completed
  • Metastatic Uveal Melanoma
  • Wirral, United Kingdom
    Clatterbridge Centre for Oncology NHS Foundation Trust
Oct 27, 2019

Clear Cell Metastatic Renal Cell Carcinoma Trial in France (Nivolumab, Ipilimumab, Pazopanib)

Completed
  • Clear Cell Metastatic Renal Cell Carcinoma
  • Bordeaux, France
  • +15 more
Apr 22, 2021

Renal Cell Carcinoma (RCC) Trial in Worldwide (Pembrolizumab, Epacadostat, Sunitinib)

Active, not recruiting
Has Results
  • Renal Cell Carcinoma (RCC)
  • Scottsdale, Arizona
  • +139 more
Jun 3, 2022

Renal Cell Carcinoma Trial in Ann Arbor, Cleveland, Nashville (Lenalidomide, Sunitinib)

Terminated
Has Results
  • Renal Cell Carcinoma
  • Ann Arbor, Michigan
  • +2 more
Nov 14, 2019

Renal Cell Carcinoma Trial in Worldwide (Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody, Bevacizumab, Sunitinib)

Completed
Has Results
  • Renal Cell Carcinoma
  • Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
  • +2 more
  • Tucson, Arizona
  • +153 more
Jan 13, 2022

Urinary Tract Urothelial Carcinoma Trial in Baltimore, Ann Arbor (Sunitinib)

Completed
Has Results
  • Urinary Tract Urothelial Carcinoma
  • Sunitinib
  • Baltimore, Maryland
  • +1 more
Sep 19, 2019

Clear Cell Renal Cell Carcinoma Trial in São Paulo (Sunitinib)

Active, not recruiting
  • Clear Cell Renal Cell Carcinoma
  • Sunitinib
  • São Paulo, Brazil
    Instituto do Cancer do Estado de São Paulo
Sep 2, 2019

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Solid Tumors Trial in Amsterdam (Sunitinib)

Completed
  • Solid Tumors
  • Sunitinib
  • Amsterdam, Netherlands
    VU University Medical Center
Jul 12, 2019

Kidney Cancer Trial in Grenoble (CK2 and ATM inhibitors serine/ threonin Kinase combination, Sunitinib, Pazopanib)

Recruiting
  • Kidney Cancer
  • CK2 and ATM inhibitors serine/ threonin Kinase combination
  • +3 more
  • Grenoble, France
    Grenoble Alps Hospital
Jan 16, 2020